Table 4 ISWI subunits with abnormal gene fusions in malignancies

Adrenocortical Carcinoma

BAZ1A

1

1

1.1%(90)

Bladder Urothelial Carcinoma

SMARCA5

1

1

0.2%(408)

Brain Lower Grade Glioma

RSF1

1

1

0.2%(511)

Breast Invasive Carcinoma

RSF1

8

8

0.8%(1070)

RBBP7

2

2

0.2%(1070)

BAZ2B

1

1

< 0.1%(1070)

RBBP4

1

1

< 0.1%(1070)

CHRAC1

1

1

< 0.1%(1070)

Prostate

SMARCA1

2

2

0.2%(494)

Lung Adenocarcinoma

BPTF

1

1

0.2%(511)

Metastatic Solid Cancers

SMARCA1

2

2

0.4%(500)

Ovarian Serous Cystadenocarcinoma

RBBP4

2

2

0.4%(523)

RSF1

1

1

0.2%(523)

Pancreatic Adenocarcinoma

BPTF

1

1

0.6%(183)

CHRAC1

1

1

0.6%(179)

Prostate

SMARCA1

2

2

0.2%(494)

Sarcoma

RSF1

2

2

0.8%(253)

RBBP7

2

2

0.8%(253)

Skin Cutaneous Melanoma

RSF1

4

4

0.9%(440)

RBBP7

1

1

0.2%(500)

Small-Cell Lung Cancer

RSF1

1

1

0.8%(125)

Uterine Corpus Endometrial Carcinoma

BAZ1B

2

2

0.4%(500)